
PHARMExcel CRO champions Fabry, MPS, and rare disease communities through year-round support and awareness initiatives
PHARMExcel champions Fabry, MPS, and rare disease communities through year-round support and awareness initiatives.
PHARMExcel champions Fabry, MPS, and rare disease communities through year-round support and awareness initiatives.
PHARMExcel celebrates new partnership for neurological clinical trial for next-generation brain-machine.
PHARMExcel engages in key discussions at global rare disease research symposium.
PHARMExcel reports on latest data for rare disease trials from 5 leading technologies.
PHARMExcel CEO to talk at Clinical Outsourcing Strategies Conference 2025.
Ways to engage patients and advocates in rare disease clinical trials.
Yvanne Enever, PHARMExcel CEO reflects on 15 years’ CRO success and what lies ahead for PHARMExcel, its clients and partners.
PHARMExcel receives honours for its clinical trial management services and partnerships.